In recent years, sustainability (ESG) has evolved from a corporate strategy to a core component of investment decision-making. With the growing market emphasis on responsible investment, investment institutions must regard ESG not only as a risk management tool, but also as a key driver for long-term value creation. From biotech innovation and digital health to circular economy, as well as healthcare accessibility and equity, sustainable investment not only enhances corporate resilience but also generates profound positive impacts on society and the environment.
To further strengthen the governance and implementation of ESG issues, Diamond Biofund resolved at the Board of Directors meeting on December 23, 2024, to elevate its sustainability governance structure. The functional committee, the “Sustainable Development and Nominating Committee,” was designated to oversee related matters and formulated medium- to long-term greenhouse gas (GHG) reduction targets. Through strategic guidance at the board level, Diamond aims to embed ESG principles more deeply into its investment and governance practices, enhance corporate resilience, align with global sustainability trends, and ultimately create greater value for shareholders and society.
In implementing responsible investment, Diamond Biofund adheres to the Principles for Responsible Investment (PRI) and has enhanced its Responsible Investment Policy, strengthened engagement and voting practices, and improved the transparency and influence of its investment decisions. Diamond also actively engages in dialogue with key portfolio companies to support their greenhouse gas (GHG) inventories and the setting of carbon reduction targets, thereby promoting low-carbon transition and enhancing the sustainability competitiveness of the biotech and healthcare industry.
During the ongoing advancement of sustainability, Diamond Biofund has achieved several representative milestones. In the “11th Corporate Governance Evaluation in 2024,” jointly organized by the TWSE and TPEx Diamond Biofund received the distinction of being in the top 5% among listed companies in its first participation. It was further ranked among the top 10% of companies in the category of “Non-Financial and Non-Electronics Enterprises with Market Capitalization Over NT$10 Billion,” demonstrating the company’s solid performance and excellence in corporate governance.
On the international front, Diamond Biofund stood out among 7,600 invited companies globally and ranked in the top 6% of the Diversified Financial Services and Capital Markets sector in the S&P Global Corporate Sustainability Assessment (CSA). Its overall score surpassed the threshold for inclusion in the 2025 S&P Sustainability Yearbook and met the entry criteria for the Emerging Markets of Dow Jones Sustainability Index (DJSI). These outstanding results affirm our commitment to sustainable operations and highlight our continued progress in environmental, social, and corporate governance (ESG) practices.
